6-Isopropyl-2-pyridin-3-ylquinoline-4-carboxylic acid
|
- $158 - $527
- Product name: 6-Isopropyl-2-pyridin-3-ylquinoline-4-carboxylic acid
- CAS: 897561-18-1
- MF: C18H16N2O2
- MW: 292.33
- EINECS:
- MDL Number:MFCD05175924
- Synonyms:6-Isopropyl-2-pyridin-3-ylquinoline-4-carboxylic acid;6-isopropyl-2-(3-pyridyl)-4-quinolinecarboxylic acid;6-isopropyl-2-(3-pyridyl)cinchoninic acid;6-isopropyl-2-(3-pyridyl)quinoline-4-carboxylic acid;6-propan-2-yl-2-pyridin-3-yl-quinoline-4-carboxylic acid;6-propan-2-yl-2-pyridin-3-ylquinoline-4-carboxylic acid;4-Quinolinecarboxylic acid, 6-(1-methylethyl)-2-(3-pyridinyl)-
3 prices
Selected condition：
Brand
- Chemenu
- Crysdot
- Matrix Scientific
Package
- 500mg
- 5g
- ManufacturerChemenu
- Product numberCM262082
- Product description6-Isopropyl-2-(pyridin-3-yl)quinoline-4-carboxylicacid 97%
- Packaging5g
- Price$497
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11025169
- Product description6-Isopropyl-2-(pyridin-3-yl)quinoline-4-carboxylicacid 97%
- Packaging5g
- Price$527
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number064759
- Product description6-Isopropyl-2-pyridin-3-ylquinoline-4-carboxylic acid
- Packaging500mg
- Price$158
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Chemenu | CM262082 | 6-Isopropyl-2-(pyridin-3-yl)quinoline-4-carboxylicacid 97% | 5g | $497 | 2021-12-16 | Buy |
| Crysdot | CD11025169 | 6-Isopropyl-2-(pyridin-3-yl)quinoline-4-carboxylicacid 97% | 5g | $527 | 2021-12-16 | Buy |
| Matrix Scientific | 064759 | 6-Isopropyl-2-pyridin-3-ylquinoline-4-carboxylic acid | 500mg | $158 | 2021-12-16 | Buy |
Properties
Boiling point :492.1±45.0 °C(Predicted)
Density :1.228±0.06 g/cm3(Predicted)
pka :2.09±0.30(Predicted)
Density :1.228±0.06 g/cm3(Predicted)
pka :2.09±0.30(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|